KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) EBT Margin (2016 - 2025)

AbbVie (ABBV) has disclosed EBT Margin for 14 consecutive years, with 16.05% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin rose 3108.0% to 16.05% in Q4 2025 year-over-year; TTM through Dec 2025 was 10.79%, a 419.0% increase, with the full-year FY2025 number at 10.79%, up 419.0% from a year prior.
  • EBT Margin was 16.05% for Q4 2025 at AbbVie, up from 4.53% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 36.41% in Q1 2022 to a low of 15.02% in Q4 2024.
  • A 5-year average of 15.15% and a median of 14.33% in 2024 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: surged 3957bps in 2021, then plummeted -3252bps in 2023.
  • AbbVie's EBT Margin stood at 28.69% in 2021, then tumbled by -32bps to 19.61% in 2022, then tumbled by -57bps to 8.47% in 2023, then tumbled by -277bps to 15.02% in 2024, then soared by 207bps to 16.05% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's EBT Margin are 16.05% (Q4 2025), 4.53% (Q3 2025), and 10.08% (Q2 2025).